These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 683753)

  • 1. [Product E, urokinase and uropepsinogen in the urine of diabetic children].
    Symonides-Lawecka A; Galczak W; Olech K; Wysocki M
    Pediatr Pol; 1978 May; 53(5):593-8. PubMed ID: 683753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of urokinase in the urine using thrombelastography and the fibrin-plate test].
    Stein G; Lindner M; Schultz C; Neumann W
    Z Gesamte Inn Med; 1974 Dec; 29(24):1027-30. PubMed ID: 4458319
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 4. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
    Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
    Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of orthostatic changes on urokinase excretion.
    Wilcox GM; Hial V; Horwitz D; Pisano JJ; Keiser HR
    Thromb Haemost; 1978 Feb; 39(1):69-73. PubMed ID: 580506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of urokinase and anticoagulant activity of the urine in patients suffering from hemorrhagic fever with renal syndrome].
    Abdurashitov RF
    Urol Nefrol (Mosk); 1977; (3):10-2. PubMed ID: 17936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urina urokinase and blood fibrinolytic activity in w experimental zinc poisoning].
    Guja A
    Patol Pol; 1977; 28(2):201-8. PubMed ID: 887291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assay method for urinary urokinase using synthetic fluorogenic substrate (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1979 Mar; 27(3):218-22. PubMed ID: 439470
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
    Shibatani T; Kakimoto T; Chibata I
    Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine.
    Husain SS; Gurewich V; Lipinski B
    Arch Biochem Biophys; 1983 Jan; 220(1):31-8. PubMed ID: 6338833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
    Chohan IS; Singh I; Vermylen J; Verstraete M
    Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of C-->T and T-->C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin resistance.
    Majsterek I; Przybylowska K; Mlynarski W; Drzewoski J; Blasiak J
    Clin Exp Med; 2005 Mar; 4(4):202-6. PubMed ID: 15750768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinogen-fibrin degradation products in diabetes mellitus].
    Alakhverdian R; Koev D
    Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.